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Abstract: 2-Bromopropane (2-BP) is used as an alternative to ozone-depleting cleaning 
solvents. Previously, we reported that 2-BP has cytotoxic effects on mouse blastocysts and 
is  associated  with  defects  in  subsequent  development.  Here, we further investigate the 
effects  of  2-BP  on  oocyte  maturation  and  subsequent  pre-  and  post-implantation 
development, both in vitro and in vivo. Notably, 2-BP induced a significant reduction in the 
rates of oocyte maturation, fertilization, and in vitro embryonic development. Treatment of 
oocytes with 2-BP during in vitro maturation (IVM) resulted in increased resorption of 
postimplantation embryos and decreased fetal weights. Experiments with a mouse model 
disclosed that consumption of drinking water containing 20 μM 2-BP led to decreased 
oocyte  maturation  in  vivo  and  fertilization  in  vitro,  as  well  as  impairment  of  early 
embryonic  development.  Interestingly,  pretreatment  with  a  caspase-3-specific  inhibitor 
effectively  prevented  2-BP-triggered  hazardous  effects,  suggesting  that  embryonic 
impairment  by  2-BP  occurs  via  a  caspase-dependent  apoptotic  process.  A  study  using 
embryonic stem cells as the assay model conclusively demonstrated that 2-BP induces cell 
death processes through apoptosis and not necrosis, and inhibits early embryo development 
in mouse embryonic stem cells. These results collectively confirm the hazardous effects   
of 2-BP on embryos derived from pretreated oocytes. 
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1. Introduction   
2-Bromopropane (2-BP), a cleaning agent, is used as an alternative to ozone-depleting solvents. In 
1995, 2-BP caused a series  of reproductive and hematopoietic disorders in  both  female and male 
workers exposed to the material. The solvent was commonly used in an electronics factory located in 
South  Korea  [1,2].  Moreover,  earlier  reports  found  a  high  incidence  of  oligozoospermia  in  male 
workers after long-term exposure to 2-BP [1–3]. Several animal studies have further confirmed the 
potential of 2-BP to  injure the reproductive, hematopoietic, central  nervous,  and immune systems 
[4–11].  In  cytotoxicity  experiments,  mouse  embryos  treated  with  2-BP  displayed  micronuclear 
formation and a decrease in embryo cell number [12]. Moreover, 2-BP was recently identified as a 
potent  DNA  damaging  agent  [5,8].  These  results  collectively  suggest  that  2-BP  induces  various 
toxicities via DNA damage. A reproductive toxicity investigation further demonstrated that exposure 
to 2-BP induced testicular or ovarian dysfunction, causing injury to early types of spermatogenic cells 
or primordial follicles and oocytes of rats [4,6]. In experiments investigating the effects of 2-BP on 
pre- and postnatal development, exposure of pregnant or lactating female rats to 2-BP resulted in 
delivery rate decrease, peri- and postnatal death increase, loss of body weight development, and higher 
incidence of reproductive organ dysfunction [13]. It is true that, to date, no clinical or epidemiological 
study, or case report, has demonstrated a direct relationship between exposure of pregnant workers to 
2-BP  and  reproductive  problems.  Specifically,  there  is  no  evidence  to  suggest  that  the  solvent 
negatively affects embryonic development or infant growth. However, it is very important to explore 
the health risks associated with exposure of female workers, especially those who are pregnant, to 
2-BP. Importantly, the solvent is very volatile and can permeate human skin. The major exposure route 
is via inhalation in the workplace or factory [1,2]. Moreover, a recent study by our group showed that 
2-BP induces cellular apoptosis in both the ICM and TE of mouse blastocysts, leading to a decrease in 
implantation, a reduction in embryonic development, and a loss of embryo viability. These results 
clearly indicate that 2-BP may be a serious risk factor affecting both the pre- and post-implantation 
stages of embryonic development. However, both the detailed effects of the solvent, and the precise 
regulatory mechanisms underlying the potentially adverse effects of 2-BP on oocyte maturation and 
early embryonic development, require further investigation. In the present study, we determine the 
effects of 2-BP on mouse oocyte maturation, fertilization, and sequential embryonic development, and 
next  attempt  to  define  the  mechanisms  involved.  Knowledge  of  the  effects  of  2-BP  on  oocyte 
maturation and fertilization in vitro is essential, particularly if pregnant women are to be exposed to   
the solvent. 
Oocyte viability is affected by the microenvironment during growth and maturation. Heat stress, 
oxygen concentration, and glucose content are key determinants of oocyte viability [14–16]. Several 
researchers have focused on the influence of environmental biological toxins on oocyte maturation   
in vivo and in vitro [17–19]. During normal embryogenesis, apoptosis (a unique morphological pattern 
of cell death) functions to remove abnormal or redundant cells in preimplantation embryos [20,21]. 
However,  apoptotic  processes  do  not  occur  prior  to  the  blastocyst  stage  during  normal  mouse 
embryonic  development  [22],  and  induction  of  cell  death  during  oocyte  maturation  and  early Int. J. Mol. Sci. 2010, 11                        
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embryogenesis  (i.e.,  via  exposure  to  a  teratogen)  leads  to  embryonic  developmental  injury 
[15,17,23–25]. Previous studies by our group demonstrated that 2-BP promotes cell apoptosis and 
developmental injury in blastocyst-stage embryos that develop from the zygote for four days [26]. 
However, the effects of 2-BP on early-stage embryogenesis, such as oocyte maturation, fertilization, 
and sequential embryo development from zygotes, are currently unclear. Here, we further investigate 
the effects of 2-BP on oocyte development by incubating with it oocytes for 24 h and comparing 
sequential development with that of oocytes in 2-BP-free conditions. We aim to determine whether 
short-term exposure to 2-BP at the oocyte stage has a long-term injurious impact on the pre- and 
post-implantation stages of embryo development. Our results clearly demonstrate that 2-BP exposure 
during the oocyte stage not only inhibits oocyte maturation but also promotes injurious effects on   
in vitro fertilization and subsequent embryonic development.   
2. Results and Discussion 
Recent  experiments  showed  that  2-BP  induces  apoptosis  and  developmental  injury  in  mouse 
blastocysts [26]. However, its effects on mouse oocyte maturation and precise regulatory mechanisms 
remain to be established. The oocyte nuclear maturation status was measured using 12 independent 
experimental replicates containing ~250 oocytes per group. The number of oocytes that reached the 
metaphase  II  (MII)  stage  of  maturation  after  IVM  was  about  94%.  A  lower  maturation  rate  was 
observed in the 5 or 10 μM 2-BP-treated oocyte group, depending on the dose of 2-BP (Figure 1). 
Male pronucleus formation was assessed for the detection of fertilization. The ability of oocytes to be 
fertilized  by  fresh  sperm  was  significantly  decreased  upon  pretreatment  with  2-BP,  prior  to  IVM   
(Figure 1).   
Figure 1. Effects of 2-BP on mouse oocyte maturation and embryo development in vitro. 
Oocytes  were  collected  from  21  day-old  mice,  cultured  for  24  h  in  IVM  medium 
containing 2-BP (2.5, 5 or 10 μM), fertilized in vitro, and transferred to in vitro culture 
(IVC)  medium.  Oocyte  maturation,  in  vitro  fertilization,  cleavage  and  blastocyst 
development were analyzed. Values are presented as means ±  SEM of 10 determinations. 
Data  are  based  on  250–260  samples  per  group.  ***P  <  0.001  versus  the  untreated   
control group. 
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We  further  analyzed  in  vitro  embryo  development  to  the  two-cell  and  blastocyst  stages.  2-BP 
pretreatment  led  to  a  significant  decrease  in  oocyte  cleavage  to  the  two-cell  stage,  indicative  of   
an  injurious  effect  (Figure  1).  In  addition,  the  number  of  embryos  cleaving  to  form  blastocysts   
in 2-BP-treated groups was significantly lower than that in the untreated control group (Figure 1).   
Following 2-BP treatment during IVM of oocytes, total blastocyst cell numbers were counted with 
a view to establishing its effects on cell proliferation. Differential staining, followed by cell counting, 
was employed to assess cell proliferation. Significantly lower blastocyst cell numbers were derived 
from 2-BP-pretreated oocytes, compared to control oocytes (Figure 2A). Additionally, the numbers of 
ICM cells in blastocysts decreased during IVM after 2-BP pretreatment (Figure 2A). However, 2-BP 
did not affect the number of trophectoderm (TE) cells present in blastocysts (Figure 2A).   
Blastocysts derived from 2-BP-pretreated oocytes was additionally evaluated for apoptosis. TUNEL 
staining  revealed  a  dose-dependent  increase  in  apoptosis  of  blastocysts  derived  from  the 
2-BP-pretreated  oocyte  group  (Figure  2B).  Quantitative  analysis  further  disclosed  a  9-  to  13-fold 
increase in apoptotic blastocysts derived from 2-BP-pretreated oocytes, compared to the control group 
(Figure 2C).   
Figure 2. Effects of 2-BP on cell number and apoptosis in embryos during IVM of oocytes. 
Oocytes  were  cultured  for  24  h  in  IVM  medium  containing  2-BP  (2.5,  5  or  10  μM), 
fertilized  in  vitro,  and  transferred  to  in  vitro  culture  (IVC)  medium  for  in  vitro 
development. (A) Cell numbers of total, trophectoderm (TE) lineages and inner cell mass 
(ICM) were counted in blastocysts. (B) Apoptotic cells were examined at the blastocyst 
stage using TUNEL staining followed by light microscopy. Positive cells are depicted in 
black.  (C)  The  mean  number  of  apoptotic  (TUNEL-positive)  cells  per  blastocyst  was 
calculated. Values are presented as means ±  SEM of eight determinations. Data are based 
on at least 280 samples in each group. ***P < 0.001 versus the untreated control group. 
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Figure 2. Cont. 
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Embryos were transferred to 50 recipients per  group (eight per horn). In total, 40 recipients were 
pregnant in at least one horn at day 18.  The implantation ratio of blastocysts derived from the oocyte 
group treated with 2-BP during IVM was significantly lower than that observed for control blastocysts 
(Figure 3A).   
To  further  determine  the  effects  of  2 -BP  on  embryo  implantation  and  post -implantation 
development, we analyzed 2-BP activity in vivo via intake and transfer of blastocyst stage embryos to 
the uterus horn using the embryo transfer assay in an animal model. Female mice were fed a standard 
diet and drinking water continuously supplemented with 2-BP (5–20 μM) or left untreated for 10 days 
before embryo transfer to the uterus during the experimental period. Embryos were transferred to 50 
recipients per group (eight per horn). A total of 40 recipients were pregnant at day 18. Notably, the 
implantation  ratio  of  blastocysts  in  the  2-BP  intake  group  was  significantly  lower  than  that  of 
blastocysts in the control group (Figure 4A). Moreover, the 2-BP intake group displayed a higher Int. J. Mol. Sci. 2010, 11                        
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overall resorption rate than the control group (Figure 4A). The embryo survival rate of the 2-BP intake 
group was markedly lower than that of control group (Figure 4A). Interestingly, the placental weights 
of blastocysts derived from the two groups were not significantly different (data not shown) while fetal 
weights were lower in the 2-BP intake (20 μM) group (Figure 4B). Based on these results, we conclude 
that exposure of embryos to 2-BP reduces the potential of embryo implantation and postimplantation 
development. 
Figure 3. Effects of 2-BP treatment or dietary 2-BP on embryo development during oocyte 
IVM. Oocytes were cultured for 24 h in IVM medium containing 2-BP (2.5, 5 or 10 μM), 
fertilized  in  vitro,  and  transferred  to  in  vitro  culture  medium  for  development.   
(A) Implantation, resorption and surviving fetuses were analyzed as described in Materials 
and  Methods.  The  implantation  percentage  represents  the  number  of  implantations  per 
number of transferred embryos ×  100. The percentage of resorption or surviving fetuses 
represents  the  number  of  resorptions  or  surviving  fetuses  per  number  of  implantations   
×  100. (B) Placental weights of 40 recipient mice were measured. (C) Weight distribution 
of surviving fetuses at  day 18 post-coitus. Surviving fetuses were obtained by embryo 
transfer of control  and  2-BP-pretreated  groups, as  described in  Materials  and Methods   
(320 total blastocysts across 40 recipients). (D) Random female mice were fed a standard 
diet and drinking water supplemented with 2-BP (5–20 μM) for 10 days or left untreated. 
Oocytes  were  collected  for  in  vitro  maturation,  in  vitro  fertilization,  cleavage,  and 
blastocyst development analyses. Data are based on at least 250 samples in each group. 
**P < 0.01 and ***P < 0.001 versus the 2-BP-free group. 
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To further clarify the precise regulatory mechanisms of 2-BP, oocytes were pretreated with 100 μM 
Ac-DEVD-cho, a caspase-3 specific inhibitor, with the aim of preventing 2-BP-triggered embryo cell 
apoptosis  during  IVM  of  oocytes.  Pretreatment  with  the  caspase-3  inhibitor  effectively  prevented 
apoptosis of blastocysts derived from the oocyte group pretreated with 10 μM 2-BP (Figure 5A). 
Notably,  the  caspase-3  inhibitor  blocked  2-BP-triggered  hazardous  effects  on  oocyte  maturation, 
fertilization  rate,  and  sequential  embryo  development  during  IVM  (Figure  5B),  and  additionally 
rescued the 2-BP-induced reduction in postimplantation development potential via embryo transfer, 
including  embryo  implantation  rate,  fetal  survival  rate,  and  fetal  development  status  (determined   
on  the  basis  of  fetal  weight;  Figure  5C).  These  results  strongly  indicate  that  the  mechanisms 
underlying 2-BP regulation of oocyte development during IVM involve apoptotic processes.   
The numbers of ICM (but not TE) cells in blastocysts decrease during IVM after 2-BP pretreatment 
(Figure 2). Accordingly, we further investigated the effects of 2-BP on embryonic cell death modes 
(such as apoptosis and necrosis) and early embryo development and differentiation using the mouse 
embryonic stem cell line ESC-B5 as the assay model. Mouse ESC-B5 cells were treated with various 
doses of 2-BP at 37 ° C
 for 24 h, and cell viability and apoptosis measured. As shown in Figure 6A, 
2-BP reduced cell viability in a dose-dependent manner. Next, we determined whether 2-BP-induced 
cell death was attributable to apoptosis. ELISA assays revealed a significant concentration-dependent 
increase in DNA fragmentation in the presence of 2-BP (Figure 6B). The percentage of apoptotic and 
necrotic cells was further analyzed by staining with propidium iodide and Hoechst 33342, and necrotic 
events assessed based on LDH activity in the culture medium. As shown in Figure 6C, the percentage 
of  apoptotic  cells  increased  significantly  at  2-BP  concentrations  higher  than  5  μM.  Under  these 
conditions, the necrotic cell population remained relatively low (Figure 6C and 6D).   
To further determine the impact of 2-BP on early embryo development in a stem cell assay model, 
cells were incubated with or without 2-BP and examined for their ability to form embryoid bodies   
in  vitro.  Embryoid  body  formation  was  significantly  decreased  in  cells  pretreated  with  2-BP   
(Figure 7A). To ascertain whether the expression levels of OCT 4 and phosphorylated STAT3 (two 
well-known pluripotent markers) are affected by 2-BP, stem cells were treated with the compound for 
24 h or left untreated. Immunoblotting experiments revealed that incubation of mouse ESC-B5 stem 
cells with 2.5, 5 or 10 μM 2-BP for 24 h had no significant effects on OCT 4 and phosphorylated 
STAT3  expression,  compared  to  the  untreated  control  group  (Figure  7B).  Moreover,  treatment  of 
embryoid body cells with 50 ng/mL nerve growth factor (NGF) for 14 days induced differentiation into 
nerve cells, along with expression of microtubule associated protein-2 (MAP-2), a major nerve cell 
biomarker. Notably, pre-treatment with 10 μM 2-BP effectively inhibited NGF-induced expression of 
MAP-2  (Figure  7C).  These  results  collectively  indicate  that  2-BP  induces  cell  death  processes 
specifically via apoptosis and inhibits early embryo development in mouse embryonic stem cells, in 
keeping with its hazardous effects on embryos derived from 2-BP-pretreated oocytes. Int. J. Mol. Sci. 2010, 11                        
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Figure 4. Effects of dietary 2-BP on embryo development in mouse blastocysts. Random 
female mice were fed a standard diet and drinking water continuously supplemented with 
2-BP (5–20 μM) or left untreated for 10 days before embryo transfer to the uterus during 
the experimental period. (A) Implantation, resorption and surviving fetuses were analyzed, 
as described in Materials and Methods. The implantation percentage represents the number 
of implantations per number of transferred embryos ×  100. The percentages of resorption 
or surviving fetuses represent the number of resorptions or surviving fetuses per number of 
implantations ×  100. (B) Weight distribution of surviving fetuses at day 18 post-coitus. 
Surviving fetuses were obtained via embryo transfer of control and 2-BP intake groups, as 
described  in  Materials  and  Methods  (320  total  blastocysts  across  40  recipients).   
***P < 0.001 versus the 2-BP-free control group. 
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Figure 5. Effects of inhibition of cell apoptosis on embryo development in 2-BP treatment 
during oocyte IVM. Oocytes were collected, cultured for 24 h in IVM medium alone or 
containing 100 μM Ac-DEVD-cho and 10 μM 2-BP, fertilized in vitro, and transferred to 
in vitro culture (IVC) medium for development. (A) Apoptotic cells were examined at the 
blastocyst stage by TUNEL staining. (B) Oocyte maturation, in vitro fertilization, cleavage 
and blastocyst  development  were analyzed.  (C)  Implantation,  resorption,  and surviving 
fetuses  were  analyzed  with  the  embryo  transfer  assay,  as  described  for  Figure  3.   
***P < 0.001 versus the untreated control group. #P < 0.001 versus 2-BP-treated group. 
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Figure 6. Effects of 2-BP on viability of the mouse embryonic stem cell line, ESC-B5. 
ESC-B5 cells were treated with the indicated doses of 2-BP for 24 h or left untreated. Cell 
viability was determined with the MTT assay (A) and apoptosis detected using ELISA (B). 
(C)  Percentages  of  apoptosis  and  necrosis  were  determined  by  staining  cells  with 
propidium iodide and Hoechst 33342. (D) Activity of LDH released in the culture medium 
of ESC-B5 cells after treatment with various concentrations of 2-BP. Data are expressed as 
a percentage of the maximal level (Max) of LDH activity determined after total cell lysis. 
Values are presented as means ±  SEM of six determinations. ***P < 0.001 versus control 
(without 2-BP treatment) group. 
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Figure 7. Effects of 2-BP on embryo development, assessed using the embryoid body 
formation assay. ESC-B5 cells were incubated with the indicated concentrations of 2-BP 
for 24 h or left untreated. (A) Cells were dissociated with trypsin-EDTA, and cultured in 
cell medium without LIF to induce differentiation. Embryoid bodies were formed with the 
hanging method, as described in Materials and Methods. (B) Cell extracts (60 μg) were 
immunoblotted with anti-p-STAT3 or OCT4 antibodies. (C) ESC-B5 cells were incubated 
with the indicated concentrations of 2-BP for 24 h or left untreated. Cells were further 
treated with 50 ng/mL nerve growth factor (NGF) for 14 days. Cell extracts (60 μg) were 
immunoblotted with anti-microtubule associated protein 2 (MAP-2) antibody. Values are 
presented as means ±  SEM. ***P < 0.001 versus the control group. 
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During the complex and precisely orchestrated process of embryonic development, chemical or 
physical injury can affect normal progression, leading to malformation or miscarriage of the embryo. 
Thus,  it  is  important  to  establish  the  possible  teratogenic  effects  of  various  chemical  agents  and 
environmental toxins. Exposure to 2-BP induces degeneration of germ cells via activation of apoptosis, Int. J. Mol. Sci. 2010, 11                        
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and spermatogonia are the major target cells [3,27]. Interestingly, 2-BP triggers apoptosis in germ cells 
through the mitochondria-dependent apoptotic signaling molecules, Bcl-2/Bax, as well as Fas-FasL 
signaling pathway interactions [27]. In a previous animal study investigating the cytotoxic effects   
of 2-bromopropane (2-BP) on rat development, rats were exposed to 0–1000 ppm 2-BP via inhalation 
for 6 h per day, seven days a week for two weeks, prior to mating during the mating period until 
copulation,  and  during  days  0–19  of  gestation.  At  a  concentration  of  1000  ppm,  inhaled  2-BP 
significantly  suppressed  the  number  of  fetuses  born,  causing  fetal  lethality  during  the 
post-implantation period [28]. Importantly, a recent study by our group showed a marked increase in 
apoptosis and decreased inner cell mass (ICM) and trophectoderm (TE) cell number in blastocysts 
treated with 5 or 10 μM 2-BP [26]. Additionally, the implantation success rates of 2-BP-pretreated 
blastocysts were lower than those of untreated controls. In vitro treatment with 5 or 10 μM 2-BP was 
associated with increased resorption of postimplantation embryos as well as decreased placental and 
fetal weights [26]. These results strongly indicate that in vitro exposure to 2-BP induces apoptosis, 
suppresses  implantation  rates  after  transfer  to  host  mice,  and  retards  early  postimplantation 
development. However, the cytotoxic effects and regulatory mechanisms of 2-BP on oocyte maturation 
and  early-stage  embryonic  development  (such  as  zygote  development  to  blastocyst)  are  unclear   
at present. 
Oocyte maturation, fertilization and embryonic development are complex processes during which 
chemical injury can lead to developmental problems or embryonic malformation. Previous studies 
report that 2-BP impairs ovarian dysfunction by causing primordial follicle damage and suppressing 
oocyte maturation in rats. Moreover, 2-BP causes major ovarian dysfunction via induction of cell 
apoptotic processes to trigger the destruction of primordial follicle and its oocytes [6]. A recent study 
by our group demonstrated that 2-BP induces apoptosis, impairment of blastocyst development from 
the morula, and promotion of early-stage death of mouse blastocysts [26]. While 2-BP is clearly a 
teratogen causing ovarian dysfunction, its  effects  and precise regulatory mechanisms  of action  on 
fertilization and zygote development remain to be ascertained, particularly, short-term exposure of 
oocytes to 2-BP and long-term early embryo development. It is important to establish the possible 
teratogenic  effects  and  regulatory  mechanisms  of  2-BP  on  oocyte  maturation,  fertilization,  and 
early-stage embryonic development (such as that from zygote to blastocyst stages). Data from the 
present study show that 2-BP inhibits mouse oocyte maturation, fertilization, and sequential embryonic 
development (Figure 1). The 2-BP-pretreated oocyte group displayed a significantly decreased cell 
number and increased apoptosis (Figure 2A and 2B). Our preliminary HPLC results show that mice 
exposed to drinking water containing 20 μM 2-BP for four days contain serum 2-BP levels of about 
5.63 μM [26]. Clearly, 5–10 μM 2-BP has injurious effects on mouse oocyte maturation, fertilization, 
and subsequent embryonic development (Figures 1–3). These hazardous effects of 2-BP are evident at 
treatment doses reflecting physiological concentrations that may be attained through dietary intake. 
The results collectively indicate that 2-BP treatment at the oocyte stage triggers both oocyte maturation 
injury  and  abnormal  apoptosis  of  cells  at  the  blastocyst  stage,  an  important  step  in  embryo 
implantation. 
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The TE arises from the trophoblast at the blastocyst stage, and develops into a sphere of epithelial 
cells surrounding the ICM and blastocoel. These cells contribute to the placenta, and are required for 
mammalian conceptus development [29]. Reduction in cells of the TE and/or ICM lineage leads to 
suppressed implantation and lower embryonic viability  [30,31]. The ICM and total blastocyst cell 
numbers are positively correlated with embryonic development during the embryo transfer assay [32]. 
Application of 2-BP during oocyte maturation had no effect on the TE cell numbers of blastocysts, but 
led to a dramatic decrease in ICM and total (TE plus ICM) cell numbers (Figure 2). Thus, it appears 
that  2-BP  treatment  during  IVM  causes  mortality  and/or  developmental  delay  in  postimplantation 
mouse  embryos  via  ICM  cell  death  or  decrease  in  proliferation  (Figures  2  and  3).  Interestingly, 
blastocysts derived from 2-BP-treated oocytes displayed decreased implantation, increased embryo 
resorption, and a lower fetal survival rate (Figure 3A), but comparable placental weight in relation to 
the control group. TE cells of embryos play important roles in implantation and placental development. 
Our results indicate that 2-BP does not exert a hazardous effect on TE cells of blastocysts (Figure 2A), 
and,  consequently,  has  no  effect  on  placental  development  (Figure  3B).  Based  on  these  data,  we 
propose that the decrease in ICM cell number induced by 2-BP during oocyte maturation is the major 
injurious factor leading to inhibition of embryonic development. 
In our experiments, 2-BP-pretreated oocytes displayed significantly decreased fertilization rates and 
cleavage to the two-cell and blastocyst stages, compared to the untreated control groups (Figure 1), 
indicative of loss of fertilization and sequent embryonic development. Moreover, in an embryo transfer 
study,  mouse  blastocyst  stage  embryos  derived  from  2-BP-pretreated  oocytes  displayed  lower 
implantation and higher resorption rates than control blastocyst-derived untreated oocytes (Figure 3A). 
Further experiments disclose that the lower embryo implantation rate and fetal weights and higher 
resorption  rate  of  blastocyst  stage  embryo  transfer  to  mouse  uterus  in  the  2-BP  intake  group  are 
significantly different from those of the 2-BP-free control group (Figure 4A and 4B). These results 
collectively  support  the  theory  that  2-BP  has  potential  hazardous  effects  on  early-stage  oocyte 
maturation and fertilization. Importantly, exposure of blastocyst embryos to 2-BP reduces the potential 
of embryo implantation and postimplantation development. 
During embryonic development, cells are often poised between proliferation and apoptosis. We 
propose that 2-BP can trigger cell death via apoptotic processes (not necrosis) and impair embryo 
development in a stem cell model (Figures 6 and 7). Incubation of mouse ESC-B5 stem cells with 5 or 
10 μM 2-BP for 24 h had no significant effects on the expression of OCT 4 and phosphorylated STAT3, 
compared to that in the untreated control group (Figure 7B). These results imply that cell apoptosis 
(Figure  6)  and  early  embryo  development  injury  (Figure  7A),  but  not  pluripotent  properties,  are 
affected by 2-BP administered over a short-term period (24 h). In addition, recent experiments by our 
group  showed  that  2-BP  exerts  cytotoxic  effects  on  mouse  blastocysts  via  induction  of  apoptosis 
processes [26]. Moreover, 2-BP pretreatment of oocytes led to decreased cell number, apoptosis, and 
delay in postimplantation development of blastocysts, compared to the control group. These injurious 
effects were prevented by pretreatment of oocytes with a caspase-3 inhibitor to suppress blastocyst 
apoptosis  (Figure  5).  The  caspase-3  inhibitor  additionally  rescued  2-BP-induced  reduction  in 
postimplantation development potential following embryo transfer, including embryo implantation rate, Int. J. Mol. Sci. 2010, 11                        
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fetal survival rate, and fetal development status. Our results indicate that 2-BP triggers improper cell 
apoptotic processes in early-stage embryos, leading to loss of embryo cell numbers and suppression of 
post-implantation  development,  further  supporting  its  role  as  a  teratogen  through  apoptosis   
induction properties.   
3. Experimental Section 
3.1. Chemicals and Reagents 
Dulbecco's  modified  Eagle's  medium  (DMEM),  2-bromopropane,  and  pregnant  mare  serum 
gonadotropin (PMSG) were obtained from Sigma (St. Louis, MO). Human chorionic gonadotropin 
(hCG) was purchased from Serono (NV Organon Oss, The Netherlands). TUNEL in situ cell death 
detection  kits  were  acquired  from  Roche  (Mannheim,  Germany),  and  CMRL-1066  medium  from 
Gibco Life Technologies (Grand Island, NY). 
3.2. COC Collection and in Vitro Maturation (IVM) 
ICR  mice  were  acquired  from  the  National  Laboratory  Animal  Center  (Taiwan,  ROC).  This 
research was approved by the Animal Research Ethics Board of Chung Yuan Christian University 
(Taiwan, ROC). All animals received humane care, as outlined in the Guidelines for Care and Use of 
Experimental Animals (Canadian Council on Animal Care, Ottawa, 1984). Mice were maintained on 
breeder chow (Harlan Teklad chow) with food and water available ad libitum. Housing was provided 
in standard 28 cm ×  16 cm ×  11 cm (height) polypropylene cages with wire-grid tops, and maintained 
under a 12 h day/12 h night regimen. Cumulus-oocyte complexes (COCs) were obtained according to a 
previous  protocol  [15]. Briefly,  COCs  were  isolated  from  female  hybrid  ICR  mice  (21  days  old) 
injected with 5 IU human chorionic gonadotrophin (hCG) 44 h prior to oocyte collection. COCs were 
collected  in  HEPES-buffered  α  minimum  essential  medium  (MEM)  (containing  50  μg/mL 
Streptomycin sulfate, 75 μg/mL Penicillin G, and 5% fetal bovine serum) by gently puncturing visible 
antral  follicles  present  on  the  ovary  surface.  Germinal  vesicle  stage  oocytes  containing  an  intact 
vestment of cumulus cells were collected and pooled in at least 10 animals. For oocyte maturation, one 
drop (~100 μL) of buffer (αMEM supplemented with 50 μg/mL Streptomycin, 75 μg/mL Penicillin G, 
5% FBS and 50 mIU/mL  recombinant human FSH) containing 10 COCs  was  added  under oil in   
35 mm culture dishes. COC maturation was analyzed following treatment with or without various 
concentrations of 2-BP (2.5, 5 or 10 μM) for 24 h under an atmosphere of 5% O2, 6% CO2 and balance 
of N2 at 37 °C . 
3.3. Maturation Status Assessment 
After  in  vitro  maturation  (IVM),  COCs  of  each  group  were  treated  with  50  U/mL  ovine 
hyaluronidase  and  gently  pipetted  for  the  removal  of  all  cumulus  cells.  Denuded  oocytes  were 
collected, and washed with fresh medium, followed by phosphate-buffered saline (PBS). Oocytes were   
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fixed in ethanol: glacial acetic acid (1:3) for 48 h, and stained with 1% aceto-orcein solution. Nuclear 
structures were visualized using phase-contrast microscopy.   
3.4. In Vivo Maturation 
For obtaining in vivo matured oocytes, 21 day-old mice were injected with 5 IU equine chorionic 
gonadotrophin (eCG) and 5 IU hCG, 61 and 13 h prior to fertilization, respectively. Mature ova were 
collected from the oviduct into HEPES-buffered α-MEM medium. 
3.5. Effects of 2-BP Intake on Oocyte Maturation in an Animal Model   
The effects of 2-BP on oocytes were analyzed in 21 day-old ICR virgin albino mice. Female mice 
were randomly divided into four groups of 20 animals each, and administered a standard diet with or 
without 5–20 μM 2-BP in drinking water for 4 days. COCs were collected by pre-treatment with 5 IU 
human chorionic gonadotrophin (hCG) for 44 h prior to oocyte collection, and analyzed for oocyte 
maturation, in vitro fertilization, and embryonic development. 
3.6. In Vitro Fertilization 
For  in  vitro  fertilization,  ova  were  washed  twice  in  bicarbonate-buffered  α-MEM  medium 
(containing 50 mg/mL  Streptomycin, 75 mg/mL Penicillin G and 3 mg/mL fatty acid free bovine 
serum albumin), and fertilized in the same medium with fresh sperm (obtained from a CBAB6F1 male 
donor). After incubation with sperm for 4.5 h, eggs were washed three times in potassium simplex 
optimized medium (KSOM) without amino acids in the presence of L-alanyl-L-glutamine (1.0 mM). 
Next, eggs were placed in 20 mL drops of KSOM under oil, and cultured overnight. During cleavage 
to the 2-cell stage, embryos were transferred to a fresh drop of KSOM under oil, and cultured for 
another 72 h. All fertilization steps and embryo culture were additionally carried out under 5% O2, 6% 
CO2 and balance of N2 at 37 º C. 
3.7. Fertilization Assessment 
For the examination of fertilization, ova were incubated with sperm for 4.5 h, followed by 3 h of 
culture in fresh medium. Zygotes were assessed for the presence of the male pronucleus with orcein 
staining, as described previously [15]. 
3.8. Cell Proliferation 
Cell proliferation was analyzed by dual differential staining, which facilitated the counting of cell 
numbers in inner cell mass (ICM) and trophectoderm (TE) [30,33,34]. Blastocysts were incubated   
with 0.4% pronase in M2-BSA medium (M2 medium containing 0.1% bovine serum albumin) for the 
removal of zona pellucida. Denuded blastocysts were exposed to 1 mM trinitrobenzenesulfonic acid 
(TNBS) in BSA-free M2 medium containing 0.1% polyvinylpyrrolidone (PVP) at 4 °C  for 30 min, and 
washed with M2 [35]. Blastocysts were further treated with 30 μg/mL anti-dinitrophenol-BSA complex Int. J. Mol. Sci. 2010, 11                        
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antibody in M2-BSA at 37 °C
 for 30 min, followed by M2 supplemented with 10% whole guinea pig 
serum as a source of complement, along with 20 μg/mL bisbenzimide and 10 μg/mL propidium iodide 
(PI) at 37 °C
 for 30 min. The immunolysed blastocysts were gently transferred to slides, and protected 
from light before observation. Under UV light, ICM cells (which take up bisbenzimide but exclude PI) 
appeared  blue,  whereas  TE  cells  (which  take  up  both  fluorochromes)  appeared  orange-red.  Since 
multinucleated cells are not common in preimplantation embryos [36], the number of nuclei represent 
an accurate measurement of cell number. 
3.9. TUNEL Assay of Blastocysts 
For  TUNEL  staining,  embryos  were  washed  in  2-BP-free  medium,  fixed,  permeabilized,  and 
subjected  to  labeling  using  an  in  situ  cell  death  detection  kit  (Roche  Molecular  Biochemicals, 
Mannheim, Germany), according to the manufacturer’s protocol. Photographic images were obtained 
with a fluorescence microscope under bright-field illumination. 
3.10. Blastocyst Development Following Embryo Transfer 
To determine the ability of expanded blastocysts to implant and develop in vivo, embryos generated 
were  transferred  to  recipient  mice.  ICR  females  (6–8  week-old,  white  skin)  were  mated  with 
vasectomized males (C57BL/6J; black skin; National Laboratory Animal Center, Taiwan, ROC) to 
produce  pseudopregnant  dams  as  recipients  for  embryo  transfer.  To  ensure  that  all  fetuses  in 
pseudopregnant  mice  were  derived  from  embryo  transfer  (white  color)  and  not  fertilization  by 
C57BL/6J (black color), we examined skin color at day 18 post-coitus. To assess the impact of 2-BP 
on postimplantation growth in vivo, COCs were exposed to 0–10 μM 2-BP for 24 h, followed by 
fertilization and in vitro maturation to the blastocyst stage. Subsequently, 8 untreated control embryos 
were transferred to the left uterine horn, and 8 2-BP-treated embryos to the right uterine horn in day 4 
pseudopregnant mice. Forty surrogate mice were analyzed and killed on day 18 post-coitus, and the 
frequency  of  implantation  calculated  as  the  number  of  implantation  sites  per  number  of  embryos 
transferred. The incidence rates of resorbed and surviving fetuses were calculated as number of fetuses 
per number of implantations, respectively. The weights of the surviving fetuses and placenta were 
measured immediately after dissection. 
3.11. Cell Culture, 2-BP Treatment and Immunoblot 
Mouse  embryonic  stem  cells  ESC-B5  were  cultured  in  DMEM  supplemented  with  20% 
heat-inactivated  fetal  bovine  serum,  100  U/mL  penicillin  and  100  μg/mL  streptomycin.  For  2-BP 
treatment, cells were incubated in media containing various concentrations of 2-BP at 37 °C
 in a CO2 
incubator for the indicated time periods. Cells were washed twice with ice-cold PBS and cell lysates 
were prepared and subjected to immunoblotting as previously described [23,37], using anti-STAT3, 
Oct4, and MAP-2 antibodies.   Int. J. Mol. Sci. 2010, 11                        
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3.12. Assessment of Necrosis and Apoptosis 
Oligonucleosomal  DNA  fragmentation  in  apoptotic  cells  was  measured  using  the  Cell  Death 
Detection ELISA
plus kit according to the manufacturer’s protocol (Roche Molecular Biochemicals, 
Mannheim, Germany). Cells (1 ×  10
5) were treated with or without 2-BP at 37 °C
 for the indicated 
time periods. Spectrophotometric data were obtained by an ELISA reader at 405 nm. Necrosis was 
assayed by determining the percentage of cells with plasma membranes permeable to propidium iodide, 
and  apoptosis  was  assayed  by  staining  with  propidium  iodide  and  Hoechest  33342.  Cells  were 
incubated with propidium iodide (1 μg/mL) and Hoechest 33342 (2 μg/mL) at room temperature for   
10 min. The percentage of apoptotic cells were determined with plasma membrane impermeable to 
propidium  iodide  and  condensed/fragmented  nuclei  stained  with  Hoechst  33342  with  fluorescent 
microscope. In each experiment, 10–12 independent fields (~600–1000 nuclei in total) were counted 
per  each  condition.  The  activity  of  lactate  dehydrogenase  (LDH)  present  in  the  culture  medium   
was  evaluated  as  an  index  of  necrosis  [38].  Cells  were  cultured  in  96-well  microtiter  plates   
(100 μL medium/well) and the absorption values at 490 nm were determined with an ELISA reader 
according to the manufacturer’s instructions (Promega, Madison, WI). Blanks were carried out adding 
test substances to medium alone. 
3.13. Embryoid Body (EB) Formation 
Embryoid bodies were formed as previously described [39]. Briefly, ESC-B5 cells were dissociated 
by trypsin-EDTA (0.25%) and cultured in LIF-free stem cell culture medium to induce differentiation. 
Cell suspension liquid cultures (<10
4 cells/mL) were dispensed to 10 cm Petri dishes at 10 mL per dish. 
Hanging drop cultures were prepared using 10 μL droplets, each containing an appropriate number of 
ESC-B5 cells for initiation of EB formation. The ESC-B5 cells were allowed to aggregate in the 
hanging drops for two days, and were then transferred to liquid suspension culture. 
3.14. Statistical Analysis 
Data were analyzed using one-way ANOVA and t-tests, and presented as means ±  SEM. Data were 
considered statistically significant at P < 0.05. 
4. Conclusions 
The study results indicate that 2-BP induces developmental injury via induction of cell apoptosis 
processes in oocyte maturation and early-stage embryos. Our findings clearly suggest that short-term 
exposure to 2-BP is a risk factor for normal mouse embryonic development, and may inhibit oocyte 
maturation in infertile subjects.   
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